-
Je něco špatně v tomto záznamu ?
Clinical experience of reoperative right ventricular outflow tract reconstruction with valved conduits: risk factors for conduit failure in long-term follow-up
M. Havova, R. Gebauer, P. Antonova, J. Spatenka, J. Burkert, O. Fabian, M. Modrak, V. Rohn
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Odkazy
PubMed
37085639
DOI
10.1007/s10561-023-10088-y
Knihovny.cz E-zdroje
- MeSH
- kojenec MeSH
- lidé MeSH
- následné studie MeSH
- reoperace MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- srdeční komory chirurgie MeSH
- vrozené srdeční vady * chirurgie MeSH
- výsledek terapie MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Reconstruction of right ventricular outflow tract in patients with congenital heart disease in various age groups remains a controversial issue. Currently, a little is known about the fate of secondary and subsequent conduit. The aim of the study was to determine risk factors of conduit failure, evaluate long-term conduit survival, find out which type of conduit should be preferred in case of reoperations. We performed a retrospective analysis of a total of 249 records of valved conduit secondary and subsequent replacement in right ventricular outflow tract in 197 patients. Median follow-up was 5.7 years. The study endpoints were defined as conduit explants; balloon dilatation of the graft (excluding balloon dilatation of left/right pulmonary artery), transcatheter pulmonary valve implantation; heart transplantation or death of the patient. There were total of 21 deaths (11% mortality) among 197 patients during the follow-up, 2 patients underwent heart transplant, in 23 implanted conduits pulmonary angioplasty or/including transcatheter pulmonary valve implantation was afterwards performed due to graft failure, conduit had to be explanted in 46 cases. After 28 years follow-up, freedom from graft failure after 5 years was 77%, 48% after 10 years and 21% after 15 years. Reoperative right ventricular outflow tract reconstruction demonstrates good mid-term and acceptable long-term outcomes regardless of the type of conduit implanted. Worse long-term graft survival of secondary and further conduits is associated with younger age of the recipient at implantation, small size of the conduit, younger age of donor and male donor in case of allograft implantation.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007024
- 003
- CZ-PrNML
- 005
- 20240423155651.0
- 007
- ta
- 008
- 240412s2024 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10561-023-10088-y $2 doi
- 035 __
- $a (PubMed)37085639
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Havova, Mariia $u Department of Cardiovascular Surgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic. mariiahavova@gmail.com $1 https://orcid.org/0000000151004325
- 245 10
- $a Clinical experience of reoperative right ventricular outflow tract reconstruction with valved conduits: risk factors for conduit failure in long-term follow-up / $c M. Havova, R. Gebauer, P. Antonova, J. Spatenka, J. Burkert, O. Fabian, M. Modrak, V. Rohn
- 520 9_
- $a Reconstruction of right ventricular outflow tract in patients with congenital heart disease in various age groups remains a controversial issue. Currently, a little is known about the fate of secondary and subsequent conduit. The aim of the study was to determine risk factors of conduit failure, evaluate long-term conduit survival, find out which type of conduit should be preferred in case of reoperations. We performed a retrospective analysis of a total of 249 records of valved conduit secondary and subsequent replacement in right ventricular outflow tract in 197 patients. Median follow-up was 5.7 years. The study endpoints were defined as conduit explants; balloon dilatation of the graft (excluding balloon dilatation of left/right pulmonary artery), transcatheter pulmonary valve implantation; heart transplantation or death of the patient. There were total of 21 deaths (11% mortality) among 197 patients during the follow-up, 2 patients underwent heart transplant, in 23 implanted conduits pulmonary angioplasty or/including transcatheter pulmonary valve implantation was afterwards performed due to graft failure, conduit had to be explanted in 46 cases. After 28 years follow-up, freedom from graft failure after 5 years was 77%, 48% after 10 years and 21% after 15 years. Reoperative right ventricular outflow tract reconstruction demonstrates good mid-term and acceptable long-term outcomes regardless of the type of conduit implanted. Worse long-term graft survival of secondary and further conduits is associated with younger age of the recipient at implantation, small size of the conduit, younger age of donor and male donor in case of allograft implantation.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a vrozené srdeční vady $x chirurgie $7 D006330
- 650 _2
- $a srdeční komory $x chirurgie $7 D006352
- 650 _2
- $a reoperace $7 D012086
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gebauer, Roman $u Children's Heart Centre, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Antonova, Petra $u Department of Cardiovascular Surgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic $1 https://orcid.org/0000000332727928
- 700 1_
- $a Spatenka, Jaroslav $u Department of Cardiovascular Surgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic $u Department of Transplantation and Tissue Bank, National Allograft Heart Valve Bank, Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000343076155 $7 jn20000402869
- 700 1_
- $a Burkert, Jan $u Department of Cardiovascular Surgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic $u Department of Transplantation and Tissue Bank, National Allograft Heart Valve Bank, Motol University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000195660527
- 700 1_
- $a Fabian, Ondrej $u Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21, Prague 4, Czech Republic $u Department of Pathology and Molecular Medicine, 3rd Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 140 59, Prague 4, Czech Republic $1 https://orcid.org/0000000279275597
- 700 1_
- $a Modrak, Martin $u Department of Bioinformatics, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Rohn, Vilem $u Department of Cardiovascular Surgery, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 15006, Prague 5, Czech Republic $1 https://orcid.org/0000000174932140
- 773 0_
- $w MED00007567 $t Cell and tissue banking $x 1573-6814 $g Roč. 25, č. 1 (2024), s. 87-98
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37085639 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155648 $b ABA008
- 999 __
- $a ok $b bmc $g 2081184 $s 1216791
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 25 $c 1 $d 87-98 $e 20230421 $i 1573-6814 $m Cell and tissue banking $n Cell Tissue Bank $x MED00007567
- LZP __
- $a Pubmed-20240412